drugset / Trial / NCT00658268

Bisphosphonates and Impaction Grafting in Hip Revision

NCT00658268

Phase 2 Completed 32 enrolled Region Skane
RandomizedParallel-groupDouble-blindTreatment

Summary

The primary focus of this study is to investigate whether increased bone density of the graft in revision arthroplasty of the hip can cause a decreased micromotion of the implant relative to the femur.

Timeline

Start
2008-03
Primary completion
2017-08-01
Completion
2017-08-01

Drugs

EvaluationDrugModalityDoseRoute
Subject clodronate Small molecule 10 ml Other
Subject clodronate Small molecule 60 mg/ml Other

Indications

No indication recorded.